Published on 8 Apr 2024 on Zacks via Yahoo Finance
Silk Road Medical, Inc. SILK recently announced the launch of its ENROUTE Transcarotid Neuroprotection System PLUS (NPS PLUS), which is a key component of the company’s Transcarotid Artery Revascularization (TCAR) portfolio.
By improving the previous ENROUTE Transcarotid Neuroprotection System, this next-generation device offers superior neuroprotection during the TCAR procedure, along with smoother arterial sheath insertion, increased flow precision, and a more straightforward prep experience for surgical teams.
Price Performance